Patient follow-up is a major problem at genetics clinics

Carmen Esmer1, Nora Urraca, Alessandra Carnevale

  • 1Departamento de Investigación en Genetica Humana, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, DF, Mexico. cesmer_98@yahoo.com

Insights

Many children with genetic diseases are lost to follow-up care, highlighting a critical need for improved patient engagement strategies in genetics clinics. This lack of consistent medical care can have serious consequences for managing these complex conditions.

Area of Science:

  • Medical Genetics
  • Clinical Follow-up Studies

Background:

  • Long-term follow-up is crucial for children with genetic diseases to identify new findings and ensure proper diagnosis.
  • Patient attrition from genetics clinics poses significant challenges and potential adverse outcomes.

Purpose of the Study:

  • To analyze patient attendance in a genetics clinic.
  • To investigate reasons for failure to seek medical advice.
  • To compare follow-up patterns between outpatient and inpatient cases.

Main Methods:

  • Retrospective review of 400 medical charts of patients with genetic diseases.
  • Analysis of patient attendance, follow-up duration, and counseling frequency.
  • Comparison of outcomes based on initial consultation type (outpatient vs. inpatient).

Main Results:

  • A significant proportion of patients, particularly those initially seen as inpatients, were lost to follow-up (179 patients).
  • Patients initially seen as outpatients had better attendance rates compared to inpatients (P = 0.0).
  • Diagnosed patients received more counseling, with a notable difference between outpatient and inpatient cases (P = 0.005).

Conclusions:

  • Maintaining patient follow-up in genetics care is challenging.
  • New educational strategies are needed to improve patient retention and adherence to medical advice.
  • Addressing patient attrition is essential for effective management of genetic diseases.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...